Cellectar Biosciences, Inc. — Director's Dealing 2017

Apr 19, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2017-04-17

Reporting Person: Friend John E. II (VP, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-04-17	Common stock	A	100000	$0.00	Acquired	100000	Direct

Footnotes

F1: Common stock grant that vests in equal annual increments over a period of three years from the date of grant.